background image

Paid Clinical Trials San Francisco

Discover 2,173 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: West Covina CA, Anaheim CA, Redlands CA, San Diego CA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
FeaturedActive & Responsive

Kegg Fertility Study

for
Fertility
Location: San Francisco CA
Sponsor: Lady Technologies Inc

Sex: Female

Age: 18 - 40

Code: NCT06862440

Recruiting
Active & ResponsiveNew

Assessing Cognitive Decline at Home

for
Mild Cognitive Impairment, Mild Dementia, Dementia Alzheimers,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 65+

Code: NCT06704971

Recruiting
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: San Francisco CA, Los Alamitos CA, Anaheim CA,
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

for
Non-infected Venous Leg Ulcer, Venous Leg Ulcer,
Location: San Francisco CA, Castro Valley CA, Oxnard CA,
Sponsor: BioStem Technologies

Sex: All

Age: 18+

Code: NCT06811909

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

CONNECTing to LungCare

for
Smoking Cessation, Cigarette Smoking-Related Carcinoma,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06213532

Recruiting
Active & Responsive

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma
Location: San Francisco CA, Aurora CO, Houston TX, Chicago IL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05169515

Phase1, Recruiting
Active & Responsive

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

for
Hypertrophic Cardiomyopathy
Location: San Francisco CA, La Jolla CA, Rochester MN, Houston TX,
Sponsor: Tenaya Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05836259

Phase1, Phase2, Recruiting
Active & Responsive

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

for
Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation,
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: University of California, San Francisco

Sex: All

Age: 13 - 39

Code: NCT03749187

Phase1, Recruiting
Active & Responsive

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: San Francisco CA, Sacramento CA, Los Angeles CA,
Sponsor: University of California, San Francisco

Sex: Female

Age: 30 - 70+

Code: NCT02620852

Recruiting